Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Patients With Advanced Breast Cancer

NCT07121244 is registered in ClinicalTrials.gov with Radionetics Oncology as lead sponsor.

NCT NCT07121244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Patients With Advanced Breast Cancer
Lead sponsor
Radionetics Oncology
Phase
Phase 1
Overall status
Terminated
Start date
October 1, 2025
Completion date
June 30, 2026
Enrollment
11 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

locoregionally recurrent hormone-receptor positive breast cancer, metastatic hormone receptor positive breast cancer